{"transactions":[{"id":2256901,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":126934,"kind":"person","name":"Maryles Joel Michael","position":1,"cik":"0001850990","reported_name":"Maryles Joel Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-05-25T16:03:50.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":11884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":11884,"derivative":{"exercise_price":27.26,"expiration_date":"2031-04-19","underlying":"American Depositary Shares","underlying_shares":11884},"source":{"system":"sec-edgar","filing":"0001178913-22-002173","document":"zk2227908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850990/000117891322002173/zk2227908.xml","form_type":"4"}},{"id":2256900,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":126934,"kind":"person","name":"Maryles Joel Michael","position":1,"cik":"0001850990","reported_name":"Maryles Joel Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-05-25T16:03:50.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vest and become exercisable in their entirety on March 16, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":6820,"derivative":{"exercise_price":3.53,"expiration_date":"2032-03-07","underlying":"American Depositary Shares","underlying_shares":6820},"source":{"system":"sec-edgar","filing":"0001178913-22-002173","document":"zk2227908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850990/000117891322002173/zk2227908.xml","form_type":"4"}},{"id":2256899,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":126934,"kind":"person","name":"Maryles Joel Michael","position":1,"cik":"0001850990","reported_name":"Maryles Joel Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2022-05-25T16:03:50.000Z","date":"2022-05-24","kind":"purchase","acquired":true,"shares":33,"price":2.76,"value":91.08,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the previously reported 1,000 ADSs of the Company, as reported by Mr. Joel Maryles on Form 4 filed with the SEC on March 21, 2022."}],"balance_after":1433,"source":{"system":"sec-edgar","filing":"0001178913-22-002173","document":"zk2227908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850990/000117891322002173/zk2227908.xml","form_type":"4"}},{"id":2256898,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":126934,"kind":"person","name":"Maryles Joel Michael","position":1,"cik":"0001850990","reported_name":"Maryles Joel Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2022-05-25T16:03:50.000Z","date":"2022-05-24","kind":"purchase","acquired":true,"shares":400,"price":2.89,"value":1156.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the previously reported 1,000 ADSs of the Company, as reported by Mr. Joel Maryles on Form 4 filed with the SEC on March 21, 2022."}],"balance_after":1400,"source":{"system":"sec-edgar","filing":"0001178913-22-002173","document":"zk2227908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850990/000117891322002173/zk2227908.xml","form_type":"4"}},{"id":2323268,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":126934,"kind":"person","name":"Maryles Joel Michael","position":1,"cik":"0001850990","reported_name":"Maryles Joel Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-03-21T06:04:46.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":11884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":11884,"derivative":{"exercise_price":27.26,"expiration_date":"2031-04-19","underlying":"American Depositary Shares","underlying_shares":11884},"source":{"system":"sec-edgar","filing":"0001178913-22-001181","document":"zk2227511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850990/000117891322001181/zk2227511.xml","form_type":"4"}},{"id":2323267,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":126934,"kind":"person","name":"Maryles Joel Michael","position":1,"cik":"0001850990","reported_name":"Maryles Joel Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-03-21T06:04:46.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options vest and become exercisable in their entirety on March 16, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":6820,"derivative":{"exercise_price":3.53,"expiration_date":"2032-03-07","underlying":"American Depositary Shares","underlying_shares":6820},"source":{"system":"sec-edgar","filing":"0001178913-22-001181","document":"zk2227511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850990/000117891322001181/zk2227511.xml","form_type":"4"}},{"id":2323266,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":126934,"kind":"person","name":"Maryles Joel Michael","position":1,"cik":"0001850990","reported_name":"Maryles Joel Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2022-03-21T06:04:46.000Z","date":"2022-03-18","kind":"purchase","acquired":true,"shares":500,"price":4.36,"value":2180.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001178913-22-001181","document":"zk2227511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850990/000117891322001181/zk2227511.xml","form_type":"4"}},{"id":2323265,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":126934,"kind":"person","name":"Maryles Joel Michael","position":1,"cik":"0001850990","reported_name":"Maryles Joel Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2022-03-21T06:04:46.000Z","date":"2022-03-18","kind":"purchase","acquired":true,"shares":500,"price":4.32,"value":2160.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001178913-22-001181","document":"zk2227511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850990/000117891322001181/zk2227511.xml","form_type":"4"}},{"id":2342236,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":126934,"kind":"person","name":"Maryles Joel Michael","position":1,"cik":"0001850990","reported_name":"Maryles Joel Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-03-09T16:01:41.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":11884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":11884,"derivative":{"exercise_price":27.26,"expiration_date":"2031-04-19","underlying":"American Depositary Shares","underlying_shares":11884},"source":{"system":"sec-edgar","filing":"0001178913-22-001018","document":"zk2227453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850990/000117891322001018/zk2227453.xml","form_type":"4"}},{"id":2342235,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":126934,"kind":"person","name":"Maryles Joel Michael","position":1,"cik":"0001850990","reported_name":"Maryles Joel Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-03-09T16:01:41.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest and become exercisable in their entirety on March 16, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":6820,"derivative":{"exercise_price":3.53,"expiration_date":"2032-03-07","underlying":"American Depositary Shares","underlying_shares":6820},"source":{"system":"sec-edgar","filing":"0001178913-22-001018","document":"zk2227453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850990/000117891322001018/zk2227453.xml","form_type":"4"}},{"id":2743186,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":126934,"kind":"person","name":"Maryles Joel Michael","position":1,"cik":"0001850990","reported_name":"Maryles Joel Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2021-04-21T17:11:35.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":11884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":11884,"derivative":{"exercise_price":27.26,"expiration_date":"2031-04-19","underlying":"American Depositary Shares","underlying_shares":11884},"source":{"system":"sec-edgar","filing":"0001104659-21-053230","document":"tm2113689-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850990/000110465921053230/tm2113689-3_4.xml","form_type":"4"}}]}